MYLILLYDIRECT
Live / Applied — Fourth extension granted (statement of use) (as of 17 Sept 2025)
What this means for you
Not registered yet, but its 01 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97657660
- Mark type
- Stylized text
- Filed
- 01 Nov 2022
- Published for opposition
- 29 Aug 2023
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceutical preparations
- Class 009 — Scientific and electric apparatus: Downloadable software for telehealth and telemedicine operations; downloadable computer software for prescribing, ordering, filling, managing, and providing information regarding prescription usage, dosage and directions; downloadable software for enabling patients to review details about medications and receive automated warnings of potential adverse interactions of medications; downloadable software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals; downloadable software for enabling patients to access general medical, health, and wellness information and advice
- Class 035 — Advertising and business services: Retail, institutional, and central fill pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail store services featuring pharmaceuticals; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceuticals; pharmaceutical services, namely, processing prescription orders
- Class 042 — Scientific and technological services: Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products
- Class 044 — Medical, beauty and agricultural services: Healthcare services; medical services; telemedicine services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2025 — SOU EXTENSION 4 GRANTED
- 17 Sept 2025 — SOU EXTENSION 4 FILED
- 17 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2025 — SOU EXTENSION 3 GRANTED
- 14 Mar 2025 — SOU EXTENSION 3 FILED
- 14 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 2 GRANTED
- 25 Sept 2024 — SOU EXTENSION 2 FILED
- 25 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2024 — SOU EXTENSION 1 GRANTED
- 14 Mar 2024 — SOU EXTENSION 1 FILED